Insights

Expansion Through Acquisition Sobi's ongoing plans to acquire Arthrosi Therapeutics for up to $1.5 billion demonstrate a strategic focus on expanding its pipeline within gout and rare disease treatments, creating opportunities for suppliers of specialized healthcare solutions, clinical services, and regulatory consulting.

Innovative Collaborations The partnership with Mavatar Technologies Inc to develop AI- and data-driven precision medicine solutions indicates a keen interest in leveraging advanced technology, presenting potential sales opportunities in AI software, data analytics, and digital health platforms.

Supply Chain Optimization Sobi's selection of Kinaxis to enhance its supply chain visibility shows an openness to adopting advanced supply chain management solutions, creating opportunities for logistics technology providers and supply chain consultation services.

Market Leadership Recognized as the top company among 31 global pharmaceutical firms by rare disease patient groups, Sobi’s strong reputation signals a potential for partnership opportunities in patient engagement platforms, medical education, and disease awareness campaigns.

Financial Growth With revenues exceeding one billion dollars and a global workforce, Sobi represents a substantial market with ongoing expansion plans, offering sales prospects in clinical trial services, manufacturing solutions, and healthcare communication tools.

Sobi - Swedish Orphan Biovitrum AB (publ) Tech Stack

Sobi - Swedish Orphan Biovitrum AB (publ) uses 8 technology products and services including Hotjar, SAS, SurveyMonkey, and more. Explore Sobi - Swedish Orphan Biovitrum AB (publ)'s tech stack below.

Hotjar

Analytics

SAS

Business Intelligence

SurveyMonkey

Customer Feedback Management

Highcharts

Javascript Graphics

ServiceNow

Miscellaneous

Determine Sourcing

Operations

Combin

Social Media Marketing Software

DHL

Transportation And Fleet Management

Sobi - Swedish Orphan Biovitrum AB (publ) Email Formats	Example	Percentage
First.Last@sobi.com	John.Doe@sobi.com	98%
First.MiddleLast@sobi.com	John.MichaelDoe@sobi.com	1%
First.Middle@sobi.com	John.Michael@sobi.com	1%

Sobi - Swedish Orphan Biovitrum AB (publ) Email Formats

Example

Percentage

First.Last@sobi.com

John.Doe@sobi.com

98%

First.MiddleLast@sobi.com

John.MichaelDoe@sobi.com

First.Middle@sobi.com

John.Michael@sobi.com

Frequently Asked Questions

Where is Sobi - Swedish Orphan Biovitrum AB (publ)'s headquarters located?

Sobi - Swedish Orphan Biovitrum AB (publ)'s main headquarters is located at 93a Norra Stationsgatan Stockholm, Stockholm 113 64 Sweden. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Sobi - Swedish Orphan Biovitrum AB (publ)'s phone number?

You can contact Sobi - Swedish Orphan Biovitrum AB (publ)'s main corporate office by phone at

+1-610-228-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sobi - Swedish Orphan Biovitrum AB (publ)'s official website and social media links?

Sobi - Swedish Orphan Biovitrum AB (publ)'s official website is sobi.com and has social profiles on LinkedIn Crunchbase.

How much revenue does Sobi - Swedish Orphan Biovitrum AB (publ) generate?

As of March 2026, Sobi - Swedish Orphan Biovitrum AB (publ)'s annual revenue is estimated to be $2.5B.

What is Sobi - Swedish Orphan Biovitrum AB (publ)'s SIC code NAICS code?

Sobi - Swedish Orphan Biovitrum AB (publ)'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sobi - Swedish Orphan Biovitrum AB (publ) have currently?

As of March 2026, Sobi - Swedish Orphan Biovitrum AB (publ) has approximately 2.2K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Cio - Chief Information Officer: C. E.Cmo Manager: S. K.Chief Information Security Officer (ciso): R. O.. Explore Sobi - Swedish Orphan Biovitrum AB (publ)'s employee directory with LeadIQ.

What industry does Sobi - Swedish Orphan Biovitrum AB (publ) belong to?

Sobi - Swedish Orphan Biovitrum AB (publ) operates in the Pharmaceutical Manufacturing industry.

What technology does Sobi - Swedish Orphan Biovitrum AB (publ) use?

Sobi - Swedish Orphan Biovitrum AB (publ)'s tech stack includes HotjarSASSurveyMonkeyHighchartsServiceNowDetermine SourcingCombinDHL.

What is Sobi - Swedish Orphan Biovitrum AB (publ)'s email format?

Sobi - Swedish Orphan Biovitrum AB (publ)'s email format typically follows the pattern of First.Last@sobi.com. Find more Sobi - Swedish Orphan Biovitrum AB (publ) email formats with LeadIQ.

Sobi - Swedish Orphan Biovitrum AB (publ)

Pharmaceutical ManufacturingStockholm, Sweden1001-5000 Employees

Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life.
Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at  sobi.com and LinkedIn.

Insights

Similar companies to Sobi - Swedish Orphan Biovitrum AB (publ)

CSL Behring

Octapharma AG

Grifols

Kedrion Biopharma

Werfen

Vertex Pharmaceuticals